Evidence map›Paper›PMID 31720798›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2020

Chloroform is a potent activator of cardiac and neuronal Kir3 channels.

Sina Kollert, Frank Döring, Ulrich Gergs, Erhard Wischmeyer

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Advances in Targeting GIRK Channels in Disease.Trends in pharmacological sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Sina KollertLaboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.
Frank DöringInstitute of Physiology, AG Molecular Electrophysiology, University of Würzburg and Center of Mental Health, University Hospital Würzburg, Würzburg, Germany.
Ulrich GergsInstitute of Pharmacology and Toxicology, Martin-Luther University Halle-Wittenberg, Halle, Germany.
Erhard WischmeyerInstitute of Physiology, AG Molecular Electrophysiology, University of Würzburg and Center of Mental Health, University Hospital Würzburg, Würzburg, Germany. e.wischmeyer@uni-wuerzburg.de.
University of Würzburg · DEMartin Luther University Halle-Wittenberg · DEUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chloroform has been used over decades in anesthesia before it was replaced by other volatile anesthetics like halothane or sevoflurane. Some of the reasons were inadmissible side effects of chloroform like bradycardia or neural illness. In the present study, we identified members of the G protein-activated inwardly rectifying potassium channel family (Kir3) expressed in Xenopus oocytes as potential common molecular targets for both the neural and cardiac effects of chloroform. Millimolar concentration currents representing a 1:10000 dilution of commercially available chloroform were used in laboratories that augment neuronal Kir3.1/3.2 currents as well as cardiac Kir3.1/3.4. This effect was selective and only observed in currents from Kir3 subunits but not in currents from Kir2 subunits. Augmentation of atrial Kir3.1/3.4 currents leads to an effective drop of the heart rate and a reduction in contraction force in isolated mouse atria.

Indexed as

AnimalsAtrial FunctionBradycardiaChloroformG Protein-Coupled Inwardly-Rectifying Potassium ChannelsHeart AtriaHEK293 CellsHumansMiceNeuronsOocytesXenopus laevisChloroformG Protein-Coupled Inwardly-Rectifying Potassium ChannelsAtrial bradycardiaChloroformG protein-activated potassium channelNeural toxicity

Identifiers

PMID31720798
OpenAlexW2983319688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.